Hypogonadism: Clinical Trials

435 trials for Hypogonadism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

279 completed, 41 unknown, 39 recruiting, 27 terminated. 100 Phase 2, 79 Phase 4, 72 Phase 3, 47 Not applicable, 44 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2100Completed 63, Terminated 9, Recruiting 7, Withdrawn 6, Not yet recruiting 5, Unknown 5, Active not recruiting 4, Enrolling by invitation 1
Phase 479Completed 53, Recruiting 7, Withdrawn 6, Terminated 5, Unknown 5, Not yet recruiting 3
Phase 372Completed 55, Recruiting 5, Unknown 4, Withdrawn 3, Not yet recruiting 2, Terminated 2, Active not recruiting 1
Not applicable47Completed 27, Unknown 11, Not yet recruiting 3, Withdrawn 3, Enrolling by invitation 2, Recruiting 1
Phase 144Completed 34, Terminated 4, Active not recruiting 3, Recruiting 1, Unknown 1, Withdrawn 1
Early Phase 15Terminated 2, Withdrawn 2, Unknown 1

Follow Hypogonadism: new trials by email Literature Review of Hypogonadism trials Research Report on Hypogonadism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
A Dose Ranging Study to Examine TDS-Testosterone 5%
Testosterone, Pump Sprayer - Hypogonadotropism
Phase 2Not yet recruitingTransdermal Delivery Solutions Corp482027-06-012026-09-30
Product Transference Study of Testagen™ TDS®-Testosterone
Testagen® TDS Testosterone 5% HypoSpray® - Hypogonadotropism
Phase 2Not yet recruitingTransdermal Delivery Solutions Corp962027-01-052026-05-27
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
Tamoxifen - Hypogonadism, Prostate Cancer
Phase 2RecruitingUniversity Health Network, Toronto962026-12-312026-10-22
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Testosterone cypionate - Prostate Cancer, Hypogonadism, Male
Phase 4RecruitingUniversity of Miami352026-11-302026-11-02
Hematological Profile in Children With Numerical Chromosomal Disorders
Down Syndrome, Turner Syndrome
Not yet recruitingAssiut University1582026-11-022026-10-29
SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
Semaglutide (Wegovy) weekly injection, Placebo weekly Injection - Craniopharyngioma, Child
Phase 3Not yet recruitingUniversity Hospital, Angers502026-11-012026-09-29
Anticipated Stigma, Illness Identity, and Quality of Life in Male Hypogonadism
Hypogonadism, Male, Endocrine Disease
RecruitingHacettepe University902026-10-202026-11-06
Exercise Self-Efficacy, Body Composition, and Physical Activity in Men With Hypogonadism
Hypogonadism, Male, Body Composition
RecruitingHacettepe University452026-10-202026-11-09
Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism
Testosterone Cypionate 75 mg, Testosterone cypionate 50 mg, Testosterone cypionate 100 mg - Male Hypogonadism
Phase 3RecruitingAmneal Pharmaceuticals, LLC1902026-09-282026-10-27
AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism
Fixed-Formula Microbiome-Targeted Oral Nutritional Supplement, Matched Oral Placebo - Hypogonadism, Male, Secondary Hypogonadism
Not applicableEnrolling by invitationVarol TUNALI1122026-08-152026-09-29
Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency
Nebido (Testosterone Undecanoate) - Frail Elderly Patients, Hypogonadal Males
Phase 2Not yet recruitingRune Skovgaard Rasmussen962026-08-012026-05-06
Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive
No intervention, hCG + FSH therapy - APHRODITE Group
Not applicableNot yet recruitingIndira IVF Hospital Pvt Ltd8602026-07-172026-04-20
A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies
Social Management Training - Sex Chromosome Disorders
Phase 1RecruitingUniversity of Oslo302026-06-012026-07-22
Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men
Observational Assessment - Testosterone Deficiency, Male Hypogonadism
RecruitingAndijan State Medical Institute6002026-06-012026-08-25
Intratesticular Artery Resistive Index Changes After Varicocelectomy
Microscopic Sub-inguinal Varicocelectomy - Varicocele, Male Infertility
Not applicableNot yet recruitingAssiut University402026-05-012026-04-08
Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism
Subcutaneous Testosterone Implants - Male Hypogonadism, Testosterone Deficiency
Phase 2Not yet recruitingUniversity of Sao Paulo302026-03-012026-03-30
Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality
Psychological Experience in Fertility Treatment, Hypogonadism
RecruitingPeter Humaidan4002026-02-132026-04-22
Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
Testosterone Cypionate Injection 200 mg/mL - Hypogonadism, Male
Phase 4Not yet recruitingAzurity Pharmaceuticals1442026-02-012026-01-09
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
kisspeptin 112-121 - Hypothalamic Amenorrhea, Hypogonadotropic Hypogonadism
Phase 2RecruitingStephanie B. Seminara, MD202025-12-092026-07-13

Showing 20 of 435. Sign in to see all of them.

Narrower conditions

Eunuchism (75)  ·  Klinefelter Syndrome (47)  ·  Obesity (25)  ·  Kallmann Syndrome (23)  ·  Sexual Infantilism (23)  ·  Turner Syndrome (19)  ·  Metabolic Syndrome (17)  ·  Erectile Dysfunction (15)  ·  Insulin Resistance (14)  ·  Diabetes Mellitus (13)  ·  Diabetes Mellitus, Type 2 (13)  ·  Endocrine System Diseases (13)  ·  Infertility (13)  ·  Infertility, Male (13)

Broader conditions

Gonadal Disorders (423)  ·  Endocrine System Diseases (422)  ·  Urogenital Diseases (154)  ·  Male Urogenital Diseases (149)  ·  Female Urogenital Diseases (107)  ·  Female Urogenital Diseases and Pregnancy Complications (107)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (103)  ·  Congenital Abnormalities (98)  ·  Urogenital Abnormalities (98)  ·  Disorders of Sex Development (95)  ·  Genetic Diseases, Inborn (82)  ·  Pathological Conditions, Signs and Symptoms (80)  ·  Nutritional and Metabolic Diseases (74)  ·  Genital Diseases (68)

Interventions

Testosterone (98)  ·  testosterone undecanoate (40)  ·  Testosterone Propionate (27)  ·  Enclomiphene (17)  ·  Gonadotropin-Releasing Hormone (17)  ·  Chorionic Gonadotropin (13)  ·  testosterone enanthate (13)  ·  testosterone 17 beta-cypionate (11)  ·  Anastrozole (9)  ·  Estradiol (8)  ·  Clomiphene (7)  ·  Sodium Chloride (7)  ·  Dutasteride (5)  ·  Exenatide (5)  ·  Natesto (5)

Sponsors

Repros Therapeutics Inc. (16)  ·  Massachusetts General Hospital (15)  ·  University of Colorado, Denver (12)  ·  Clarus Therapeutics, Inc. (11)  ·  Gulhane School of Medicine (11)  ·  University of Aarhus (9)  ·  Acerus Pharmaceuticals Corporation (7)  ·  Bayer (7)  ·  Rhythm Pharmaceuticals, Inc. (7)  ·  University of Washington (7)  ·  VA Office of Research and Development (7)  ·  Baylor College of Medicine (6)  ·  Eli Lilly and Company (6)  ·  Stephanie B. Seminara, MD (6)  ·  Antares Pharma Inc. (5)

Countries

United States (242)  ·  Denmark (30)  ·  United Kingdom (24)  ·  Italy (20)  ·  Germany (17)  ·  Turkey (Türkiye) (16)  ·  Canada (12)  ·  France (11)  ·  Netherlands (9)  ·  China (8)  ·  Spain (8)  ·  Brazil (6)  ·  Russia (6)  ·  Australia (5)  ·  South Korea (5)

Top investigators

David Meeker, MD (6)  ·  Stephanie B Seminara, MD (6)  ·  Ronald Swerdloff, MD (5)  ·  Stephanie Seminara, MD (5)  ·  Abraham Morgentaler, MD (4)  ·  Ranjith Ramasamy, MD (4)  ·  Sandeep Dhindsa, MD (4)  ·  Anthony DelConte, MD (3)  ·  Joseph S Podolski (3)  ·  Natalie D Shaw, M.D. (3)  ·  Shanlee M Davis, MD (3)

Results publications

PMID 38224135, PMID 28981994, PMID 31132118, PMID 32034419, PMID 36978128, PMID 21209029, PMID 21474786, PMID 23643382, PMID 27992261, PMID 29669934, PMID 32542985, PMID 32870266, PMID 35027909, PMID 36272969, PMID 38606384, PMID 38852333, PMID 10664066, PMID 11502778, PMID 11531930, PMID 11788640, PMID 11836290, PMID 12213860, PMID 12788881, PMID 14573733, PMID 15230699, PMID 15613419, PMID 16291975, PMID 16352669, PMID 16606836, PMID 16757106, PMID 16764984, PMID 16801584, PMID 16882745, PMID 17074994, PMID 17334928, PMID 17371886, PMID 17510436, PMID 17535868, PMID 17635942, PMID 17761590, PMID 17959774, PMID 17983892, PMID 18073301, PMID 18077826, PMID 18270253, PMID 18272894, PMID 18445673, PMID 18567642, PMID 18996225, PMID 19021638

NIH funding

U54HD028138 (4), 2009 (2), 2017 (2), K23HD045386 (2), UL1TR001082 (2), 2005 (1), 2008 (1), 2014 (1), 2015 (1), 2016 (1), 2018 (1), 2023 (1), I01CX001665 (1), I01RX001449 (1), K12HD057022 (1)